SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 21
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 ... 18 19 20 21
|
presentations:
1 to
50 of
1003
|
Session Overview
Javier Martinez-Pìcado
IrsiCaixa, Badalona, Spain
Effect of ART Start Time, ART Duration, and Elite Control on HIV Transcription (ABSTRACT
495)
Adam Wedrychowski
San Francisco VA Medical Center, San Francisco, CA, USA
Viral Reservoir Characteristics in Lymphoid Tissues of HIV-1 Elite Controllers (ABSTRACT
496)
Samantha K. Marzi
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
CD8+ T Cells Shape the HIV Integration Site Landscape According to the Degree of T-Cell Pressure (ABSTRACT
497)
R. Bradley Jones
Weill Cornell Medicine, New York, NY, USA
Anti-IL-10/Anti-PD-1 Dual Blockade Leads to IFN-Related HIV Elite Control Signatures (ABSTRACT
498)
Susan P. Ribeiro
Emory University, Atlanta, GA, USA
Loss of Virological Control 32 Years After HIV-1 Diagnosis in an Exceptional Elite Controller (ABSTRACT
494)
Anna Pons-Grífols
IrsiCaixa, Badalona, Spain
Discussion with Audience Q&A
Session Overview
Anoop Shah
London School of Hygiene & Tropical Medicine, London, UK
Mitochondrial Haplogroups and Left Ventricular Dysfunction in People Living With and Without HIV (ABSTRACT
813)
Craig Cronin
The Johns Hopkins Hospital, Baltimore, MD, USA
Sex Differences in Myocardial Steatosis in South African Youth With Perinatally-Acquired HIV (ABSTRACT
811)
Morne Kahts
University of Cape Town, Cape Town, South Africa
Physician-Confirmed Incident Heart Failure Phenotypes and Etiologies Within CNICS (ABSTRACT
814)
Matthew J. Feinstein
Northwestern University, Chicago, IL, USA
Readmission Risk for Adults With HIV Hospitalized for Heart Failure or Acute Myocardial Infarction (ABSTRACT
815)
Ping Yang
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Heart Failure Among People With HIV: Prescription of Guideline-Directed Medical Therapy (ABSTRACT
812)
Melissa K. Cutshaw
Duke University School of Medicine, Durham, NC, USA
Discussion with Audience Q&A
Session Overview
Mateo Prochazka
World Health Organization, Geneva, Switzerland
National HIV Self-Test Distribution Program: HIV Testing, Diagnosis and Treatment, 3/2023 - 5/2024 (ABSTRACT
1178)
Patrick S. Sullivan
Emory University, Atlanta, GA, USA
Estimating Need for Annual HIV Testing Met by a Nationwide Mailed HIV Self-Testing Program (ABSTRACT
1179)
Jen Hecht
Moderators of a Home-Based Couple Intervention on Couple HIV Testing and Counselling Uptake in Kenya (ABSTRACT
1181)
Zachary A. Kwena
Kenya Medical Research Institute-UCSF Infectious Disease Research Training Program, Kisumu, Kenya
Discussion with Audience Q&A
Session Overview
James A. Hoxie
University of Pennsylvania, Philadelphia, PA, USA
Validation of Quantification of Lesional KSHV DNA Content for Diagnosis of Kaposi Sarcoma in Africa (ABSTRACT
789)
Aggrey Semeere
Infectious Diseases Institute, Kampala, Uganda
Impact of Low-Dose Intra-Lesional Nivolumab for Kaposi Sarcoma on T-Cell Proliferation and Function (ABSTRACT
792)
Chia-Ching Wang
University of California San Francisco, San Francisco, CA, USA
Immunologic Responses to Pomalidomide and Liposomal Doxorubicin for Kaposi Sarcoma Treatment (ABSTRACT
791)
Matthew Witterholt
National Cancer Institute, Bethesda, MD, USA
Causes of Death Among Adults With HIV-Associated Kaposi Sarcoma in East Africa in the Treat All Era (ABSTRACT
794)
Helen Byakwaga
Infectious Disease Institute, Kampala, Uganda
Genome Evolution of Kaposi Sarcoma-Associated Herpesvirus (KSHV) in PLWH (ABSTRACT
796)
Dirk P. Dittmer
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Discussion with Audience Q&A
Session Overview
Tonia Poteat
Duke University, Durham, NC, USA
Recent HIV Acquisition Among Transgender Women From Midwest Brazil (ABSTRACT
1108)
Sylvia L. M. Teixeira
Oswaldo Cruz Institute – Fiocruz, Rio de Janeiro, Brazil
High HIV Burden Among Transgender Women in the State Capital and Rural Towns in Central Brazil (ABSTRACT
1109)
Bruno Vinícius D. Diniz e Silva
Federal University of Goias, Goiânia, Brazil
Time to Antiretroviral Initiation Among Transgender Women Living With HIV in France (1997-2022) (ABSTRACT
1110)
Juliette Hemery
French National Institute of Health and Medical Research (Inserm), Paris, France
Discussion with Audience Q&A
Scientific Overview of Machine Learning: Gearing Up for the Future
Julia Marcus
Harvard Pilgrim Health Care Institute, Boston, MA, USA
Machine Learning to Predict Persons With HIV at Risk of Falling Out of Care (ABSTRACT
1307)
Thomas Martin
University of California San Diego, La Jolla, CA, USA
Enhanced Language Models for Predicting and Understanding HIV Care Disengagement (ABSTRACT
1313)
Waverly Wei
University of Southern California, Los Angeles, CA, USA
An AI-Powered Preventive Intervention for Stigma and Suicidal Ideation in HIV Self-Management (ABSTRACT
1308)
Diego S. Villanueva Guzman
Research Institute of McGill University Health Centre, Montreal, Canada
Discussion with Audience Q&A
Session Overview
Galit Alter
Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA
HLA-E Prevents Natural Killer Cell Inhibition of HIV-1 Replication in Peripheral Blood CD4+ T Cells (ABSTRACT
446)
Amanda M. Dudek
Stanford University, Stanford, CA, USA
Differential CD8T/NK Cell-Mediated HIV-1 Control After TIGIT or KLRG1 Blockade and ART in hBLT Mice (ABSTRACT
447)
Ildefonso Sánchez-Cerrillo
Hospital Universitario de La Princesa, Madrid, Spain
Elucidating the Role of Natural Killer Cells in Antibody Breadth During HIV Infection (ABSTRACT
448)
Izumi de los Rios Kobara
Stanford University, Stanford, CA, USA
NF-kappa-B Signaling in Natural Killer Cells Predicts Post-Treatment HIV Control (ABSTRACT
445)
Ashley F. George
Gladstone Institutes, San Francisco, CA, USA
RV550: IL-15 Superagonist N-803 With ART in Acute HIV Infection Enhances T and NK Cell Proliferation (ABSTRACT
444)
Hiroshi Takata
Oregon Health and Science University, Portland, OR, USA
Discussion with Audience Q&A
Session Overview
Alex Sigal
Africa Health Research Institute, Mtubatuba, South Africa
SARS-CoV-2 Intra-Host Evolution During Acute Infection in People With COVID-19 (ABSTRACT
313)
Agostino Riva
University of Milan, Milan, Italy
Evolving of Immune Evasion During a SARS-CoV-2 Chronic Infection: A Pathway to Variants of Concern (ABSTRACT
311)
Rui Galao
King's College London, London, UK
Genetic Mutation Differences Patterns of SARS-CoV-2 in Immunocompromised Patients Versus Controls (ABSTRACT
312)
Karen Zafilaza
Assistance Publique – Hôpitaux de Paris, Paris, France
ScRNA-seq of HRSV/SARS-CoV-2 Co-Infection Reveals Unique Cellular Responses and lncRNA Signatures (ABSTRACT
309)
Claudia Vanetti
University of Milan, Milan, Italy
Prevalence, Spread, and Mutation of SARS-CoV-2 Variants in COVID-19 Testing in Salvador, Brazil (ABSTRACT
314)
Anna Carolina Dantas
Federal University of Bahia, Salvador, Brazil
Discussion with Audience Q&A
|
<< first | < prev
page:
of 21
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 ... 18 19 20 21
|
presentations:
1 to
50 of
1003
|
